NUVATION BIO INC (NUVB)

US67080N1019 - Common Stock

1.4  +0.01 (+0.72%)

After market: 1.44 +0.04 (+2.86%)

NUVATION BIO INC

NYSE:NUVB (9/27/2023, 7:04:01 PM)

After market: 1.44 +0.04 (+2.86%)

1.4

+0.01 (+0.72%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)08-03 2023-08-03/amc
Earnings (Next)11-01 2023-11-01/amc
Ins Owners0.01%
Inst Owners63.57%
Market Cap306.52M
Shares218.94M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts80
IPO07-01 2020-07-01
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

NUVB Daily chart

Company Profile

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company is headquartered in San Francisco, California and currently employs 54 full-time employees. The company went IPO on 2020-07-01. The firm is focused on developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes mechanistically distinct oncology therapeutic product candidates, each targeting some of the difficult-to-treat types of cancer. The Company’s clinical-stage product candidate, NUV-868, is a BD2-selective oral small molecule bromodomain and extra terminal (BET) inhibitor. NUV-868 inhibits the protein BRD4, a member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. The company has designed NUV-868 to reduce the therapeutic limiting toxicities of BRD4 inhibitors in development by optimizing BD2 versus BD1 selectivity. Its drug-drug conjugate (DDC) platform is a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

Company Info

NUVATION BIO INC

357 Tehama Street, Floor 3

San Francisco CALIFORNIA 94103

P: 14157543517.0

CEO: David Hung

Employees: 54

Website: https://www.nuvationbio.com/

NUVB News

News Image3 days ago - Market News VideoTop Buys by Directors: Nodelman's $6.7M Bet on NUVB
News Image3 days ago - Market News VideoMonday 9/25 Insider Buying Report: NUVB, ADC
News Image2 months ago - Nuvation Bio Inc.Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
News Image4 months ago - Nuvation Bio Inc.Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board
News Image5 months ago - Seeking Alpha(NYSE:NUVB)

Nuvation Bio press release (NUVB): Q1 GAAP EPS of -$0.10.Strong balance sheet with cash, cash equivalents and marketable securities of $646.6 million as of March 31, 2023

News Image5 months ago - Nuvation Bio Inc.Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

NUVB Twits

Here you can normally see the latest stock twits on NUVB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example